FDA Approves FoundationOne CDx as Companion Diagnostic Test for Piqray Treatment
News
The U.S. Food and Drug Administration (FDA) has approved Foundation Medicine’s FoundationOne CDx as a companion diagnostic test for identifying advanced breast cancer patients with a PIK3CA mutation suitable for ... Read more